EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

CONCEPT OF WABA (EPIDEMIC) AND PREVENTION AND TREATMENT OF COVID-19 IN VIEW OF TIBB-E-UNANI

Maryam Zafar*, Tabassum Latafat, Badrudduja Khan, Mursaleen Naseer, Amreen Zehra, Kehkashan Yasra Farooqui

ABSTRACT

Background and Objective: The world's focus has been on exploring ways to strengthen host defenses due to the lack of availability of clinically validated prophylaxis and specific coronavirus medicines (COVID-19). The Unani system of medicine is one of the conventional systems of medicine that is being explored for the provision of preventive, therapeutic and rehabilitative treatment to patients. Hippocrates (460-380BC), the father of medicine, authored books on Epidemics. Unani scholars identified the host as an important determinant of disease dynamics and placed significant emphasis on host defense. The purpose of this article was therefore to provide an outline of the fundamental concept of Waba and to explain COVID-19 in relation to the existing literature on Tibb-e-Unani. Materials and Methods: To gather the data on the steps recommended for disease control, a manual literature survey of classical Unani texts was performed. In addition, electronic databases such as PubMed, Google Scholar, and Science Direct were searched to identify researches conducted on Unani drugs listed in the article as well as to obtain recent information about COVID-19 outbreak. The keywords used were “Unani Medicine,” “Epidemic,” “Immunomodulator,” “Antiviral,” “Antimicrobial,” “Prevention,” and “COVID-19.” Results: The literature review shows that Unani scholars have given an elaborate description of the epidemic including its definition, etiological factors, susceptible host, clinical presentation of infected individuals, and the containment measures. Conclusion: The aforesaid Unani literature and contemporary materials seem to be of much relevance in today‟s context. These preventive measures have been considered useful in reducing the risk of contracting the infection during epidemics. Hence, in our opinion, it is worth assessing them in the current outbreak.

Keywords: COVID-19, epidemic, host defense, immunomodulator, Unani medicine.

[Full Text Article] [Download Certificate]